A

Apricus Biosciences, Inc (NASDAQ:APRI)

8 employees

Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology

Pharmaceutical

Health Care

Date founded

1987

FAQ